German stocks traded lower on Monday, with Bayer AG shares plunging to a 12-year low after aborting a large late-stage trial testing a new anti-clotting drug due to lack of efficacy.
Read Full Story
Latest posts by Business Editor (see all)
- Tips for Entrepreneurs Starting a New Business in 2024 - December 4, 2023
- European Stocks Close Lower In Cautious Trade Ahead Of Crucial Economic Data - November 27, 2023
- European Shares Slip Into Red On China Concerns - November 27, 2023
